<DOC>
	<DOCNO>NCT02064946</DOCNO>
	<brief_summary>The purpose study test efficacy high-dose vitamin D supplementation regimen reduce androgen deprivation therapy ( ADT ) -related side effect older prostate cancer patient ADT . The propose study randomize , double-blind , 2-arm , control clinical trial accrue 76 prostate cancer patient without severe bone loss , age 60 old , begin ADT , schedule receive least 6 month ADT . Participants randomize : 1 ) weekly high-dose vitamin D3 ( 50,000 IU ) 2 ) vitamin D placebo period 24 week . Both group also receive daily multivitamin calcium supplement .</brief_summary>
	<brief_title>High-dose Vitamin D Supplementation ADT-induced Side Effects</brief_title>
	<detailed_description>The investigator hypothesize high-dose vitamin D supplementation reduce androgen deprivation therapy ( ADT ) -related side effect include ADT-induced bone loss , decreased muscle mass , fall , reduce muscle strength , diminish physical performance old prostate cancer patient . The vitamin D supplementation aim reduce fracture risk maintain proper bone density , thereby prevent osteoporotic/osteopenic condition increase muscle mass . Both vitamin D exercise efficacious maintain proper bone health muscle mass among general population , little research do prostate cancer patient survivor . Vitamin D could reduce fracture risk among prostate cancer survivor .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Have confirm diagnosis stage IIIIA prostate cancer Within 6 month start ADT additional 6 month plan . Participants must suboptimal vitamin D level &lt; 32 ng/ml . Participants must agree take calcium and/or vitamin D supplement duration intervention provide . Participants must ionize serum calcium level within normal limit ( 1.191.29mmol/L ) total correct serum calcium ≤10.5 mg/dl . No contraindication fitness test physical limitation ( e.g . cardiorespiratory , orthopedic , nervous system ) assess physician . Able read English ( since assessment material print format ) . Able swallow medication provide write informed consent . 60 year age old . Previously verify diagnosis osteoporosis ( tscore ≤ 2.5 ) . Patients antiresorptive drug ( i.e . bisphosphonates ) within past year . Patients hypercalcemia ( correct serum Ca &gt; 10.5 mg/dl ) history hypercalcemia vitamin D toxicity/sensitivity . Patients impaired renal function ( CrCl &lt; 60 mL/min ) kidney stone ( calcium salt ) within past 5 year . Myocardial infarction within past year .</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>bone density</keyword>
	<keyword>vitamin D</keyword>
	<keyword>micronutrient</keyword>
	<keyword>pharmacologic action</keyword>
</DOC>